DYNAVAX TECHNOLOGIES CORPORATION Amended and Restated MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENTManagement Continuity and Severance Agreement • November 5th, 2020 • Dynavax Technologies Corp • Pharmaceutical preparations • California
This Amended and Restated Management Continuity and Severance Agreement (the “Agreement”) is dated as of September 22, 2020, by and between Michael S. Ostrach (“Employee”) and Dynavax Technologies Corporation, a Delaware corporation (the “Company”).
SUPPLY AGREEMENTSupply Agreement • November 5th, 2020 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
This Supply Agreement (the “Agreement”), which shall become effective in accordance with Section 10.1, is entered into by and between Dynavax Technologies Corporation, a Delaware corporation, with a place of business located at 2100 Powell Street, Suite 900, Emeryville, CA 94608, USA (“Dynavax”), and Valneva Scotland Limited, a company organized under the laws of Scotland, with its principal place of business at Oakbank Park Rd, Livingston EH53 0TG, United Kingdom (“Purchaser”), and Valneva Austria GmbH, a company registered in Austria (company number FN 389960 x /HG Wien) whose registered address is at Campus Vienna Biocenter 3, 1030 Vienna, Austria (“Valneva Austria”). Dynavax and Purchaser may be referred to herein individually as a “Party” or collectively as the “Parties”.
AMENDMENT NO. 3 TO TERM LOAN AGREEMENTTerm Loan Agreement • November 5th, 2020 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 3 TO TERM LOAN AGREEMENT, dated as of November 2, 2020 (this “Agreement”), is made among Dynavax Technologies Corporation, a Delaware corporation (the “Borrower”), the Subsidiary Guarantors party hereto, the Lenders party hereto and CRG Servicing LLC, as administrative agent and collateral agent (in such capacities, “Agent”), with respect to the Loan Agreement referred to below.
